PubRank

Maurizio Martini

Author PubWeight™ 56.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res 2008 2.52
2 Targeted therapy with bevacizumab and erlotinib tailored to the molecular profile of patients with recurrent glioblastoma. Preliminary experience. Acta Neurochir (Wien) 2012 1.99
3 Role of p16/INK4a in gastrointestinal stromal tumor progression. Am J Clin Pathol 2004 1.54
4 Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis. Haematologica 2008 1.54
5 MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia. Leuk Lymphoma 2012 1.51
6 Mutations of the BIK gene in human peripheral B-cell lymphomas. Genes Chromosomes Cancer 2003 1.50
7 Endothelial progenitor cell trafficking in human immunodeficiency virus-infected persons. AIDS 2010 1.45
8 Endothelial progenitor cells in HIV-positive patients: what are we talking about? J Acquir Immune Defic Syndr 2013 1.42
9 Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. Clin Cancer Res 2009 1.22
10 Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. Blood 2007 1.19
11 The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma. Clin Cancer Res 2011 1.18
12 Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis. Haematologica 2009 1.15
13 Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia. J Clin Oncol 2007 1.10
14 Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis. Cancer 2010 1.07
15 Primary cerebral lymphomatoid granulomatosis: report of four cases and literature review. J Neurooncol 2009 1.06
16 Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior. Prostate 2010 1.06
17 Endothelial progenitor cells are clonal and exhibit the JAK2(V617F) mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms. Blood 2011 1.05
18 Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? Clin Colorectal Cancer 2011 1.02
19 Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia. Haematologica 2009 0.99
20 Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome. Blood 2012 0.98
21 Genome wide DNA-profiling of HIV-related B-cell lymphomas. Br J Haematol 2009 0.97
22 Expression of EGFRvIII in glioblastoma: prognostic significance revisited. Neoplasia 2011 0.97
23 BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma. Cancer Cytopathol 2012 0.93
24 Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome. Br J Haematol 2012 0.93
25 The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia. Blood 2007 0.91
26 Soft tissue non-Hodgkin lymphoma of shoulder in a HIV patient: a report of a case and review of the literature. World J Surg Oncol 2008 0.91
27 Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases. Int J Cancer 2008 0.89
28 Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma. Am J Clin Pathol 2012 0.89
29 Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. Leuk Res 2009 0.88
30 Mutations of CD79A, CD79B and EZH2 genes in immunodeficiency-related non-Hodgkin lymphomas. Br J Haematol 2011 0.87
31 Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma. Leuk Lymphoma 2007 0.87
32 Thyroglossal duct cyst cancer most likely arises from a thyroid gland remnant. Virchows Arch 2014 0.86
33 Molecular history of Richter syndrome: origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis. Int J Cancer 2011 0.86
34 Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. Clin Transl Gastroenterol 2012 0.85
35 Unusual focal keratin expression in plexiform angiomyxoid myofibroblastic tumor: A case report and review of the literature. Medicine (Baltimore) 2016 0.85
36 Diagnostic and prognostic value of immunocytochemistry and BRAF mutation analysis on liquid-based biopsies of thyroid neoplasms suspicious for carcinoma. Eur J Endocrinol 2013 0.84
37 Endoscopic ultrasound-guided fine-needle aspiration with liquid-based cytologic preparation in the diagnosis of primary pancreatic lymphoma. Pancreas 2010 0.84
38 Von hippel-lindau disease and erythrocytosis. J Clin Oncol 2012 0.83
39 Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. Leuk Lymphoma 2011 0.81
40 Dysregulated expression of Bcl-xL in CD34+ cells isolated from patients with refractory anemia with excess of blasts during megakaryocytic differentiation. Haematologica 2002 0.81
41 Characterization of Epstein-Barr virus genotype in AIDS-related non-Hodgkin's lymphoma. AIDS Res Hum Retroviruses 2002 0.81
42 The role of thyroid fine-needle aspiration cytology in the pediatric population: an institutional experience. Cancer Cytopathol 2014 0.80
43 Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. Eur J Gastroenterol Hepatol 2007 0.79
44 Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia. J Clin Oncol 2002 0.79
45 Thrombopoietin receptor activation, thrombopoietin mimetic drugs, and hereditary thrombocytosis: remarks on bone marrow fibrosis. J Clin Oncol 2010 0.79
46 Images in endocrine pathology: spindle cell lesion of the thyroid gland. Endocr Pathol 2012 0.78
47 Effect of antiviral therapy on pro-angiogenic hematopoietic and endothelial progenitor cells in HIV-infected people. Thromb Res 2013 0.78
48 Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: a cytohistologic institutional experience. Cancer Cytopathol 2014 0.78
49 Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma. Hematol Oncol 2012 0.78
50 Morphological parameters able to predict BRAF(V600E) -mutated malignancies on thyroid fine-needle aspiration cytology: Our institutional experience. Cancer Cytopathol 2014 0.77
51 The cytologic category of oncocytic (Hurthle) cell neoplasm mostly includes low-risk lesions at histology: an institutional experience. Eur J Endocrinol 2013 0.77
52 Papillary thyroid microcarcinoma: a painstaking category to manage. Clin Endocrinol (Oxf) 2014 0.77
53 Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin. Neoplasia 2013 0.76
54 Pyrosequencing evaluation of low-frequency KRAS mutant alleles for EGF receptor therapy selection in metastatic colorectal carcinoma. Future Oncol 2014 0.76
55 DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma. Haematologica 2006 0.76
56 Is thyroid gland only a "land" for primary malignancies? role of morphology and immunocytochemistry. Diagn Cytopathol 2014 0.76
57 Gastrointestinal stromal tumors (GISTs) and second malignancies: A novel "sentinel tumor"? A monoinstitutional, STROBE-compliant observational analysis. Medicine (Baltimore) 2016 0.75
58 The PRV-1 gene expression in essential thrombocythemia. Blood 2004 0.75
59 Hu/elav RNA-binding protein HuR regulates parathyroid hormone related peptide expression in human lung adenocarcinoma cells. Histol Histopathol 2013 0.75
60 Detection of ectopic thyroid remnants: a serious diagnostic dilemma. When molecular biology and immunohistochemistry can solve the problem. Pathol Res Pract 2012 0.75
61 Absence of structural mutations of the BAK gene in B cell lymphomas. Haematologica 2002 0.75
62 The mutant JAK2 allele burden in children with essential thrombocythemia. Br J Haematol 2009 0.75
63 Myeloid sarcoma with megakaryoblastic differentiation mimicking a sellar tumor. Neuropathology 2013 0.75
64 Cytopathology of Follicular Cell Nodules. Adv Anat Pathol 2017 0.75
65 Neurofibromatosis 1 presenting with multiple duodenal GISTS associated with a somatostatin-producing D cell neoplasm. Endocr Pathol 2013 0.75
66 Difference in clonality as a tool for differential diagnosis of primary versus secondary lung neoplasms. J Thorac Oncol 2012 0.75
67 Short communication: proangiogenic hematopoietic cells in acute HIV infection. AIDS Res Hum Retroviruses 2013 0.75
68 The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies With Aggressive Behavior. Appl Immunohistochem Mol Morphol 2016 0.75
69 Well-differentiated thyroid cancer with a minor poorly differentiated component: clonal heterogeneity through the prognostic role of CXCR4 and BRAF analysis. Appl Immunohistochem Mol Morphol 2015 0.75
70 Autosomal dominant Ménétrier-like disease. J Pediatr Gastroenterol Nutr 2012 0.75
71 Cribriform-morular variant of papillary thyroid carcinoma in an 8-year-old girl: a case report with immunohistochemical and molecular testing. Int J Surg Pathol 2012 0.75